{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F852024-contralateral-risk-uyJhuGN0","width":444,"version":"1.0","type":"rich","title":"8.5.2024 - Contralateral Risk","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/eb642477-d328-4557-8b05-cc26207d2bc7\" height=\"200\" width=\"100%\" title=\"8.5.2024 - Contralateral Risk\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's QuadCast as we highlight the benefits or lack thereof for prophylactic contralateral mastectomy, the benefits of bone marrow sparing IMRT in cervical cancer, the best concurrent cisplatin dosing regimen for H&N cancer, and more."}